2022
Simon D, Tascilar K, Fagni F, Krönke G, Kleyer A, Meder C, Atreya R, Leppkes M, Kremer AE, Ramming A, Pachowsky ML, Schuch F, Ronneberger M, Kleinert S, Hueber AJ, Manger K, Manger B, Berking C, Sticherling M, Neurath MF, Schett G. SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases.
Ann Rheum Dis. 2021 Oct;80(10):1312-1316. doi: 10.1136/annrheumdis-2021-220461. Epub 2021 May 6.
PMID: 33958324
Simon D, Tascilar K, Fagni F, Schmidt K, Krönke G, Kleyer A, Ramming A, Schoenau V, Bohr D, Knitza J, Harrer T, Manger K, Manger B, Schett G. Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease.
Ann Rheum Dis. 2022 Jul;81(7):1023-1027. doi: 10.1136/annrheumdis-2021-221554. Epub 2021 Nov 24.
PMID: 34819271
Fagni F, Schmidt K, Bohr D, Valor-Méndez L, Hartmann F, Tascilar K, Manger K, Manger B, Kleyer A, Simon D, Schett G, Harrer T. Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination.
RMD Open. 2022 May;8(1):e002323. doi: 10.1136/rmdopen-2022-002323.
PMID: 35589333 Free PMC article. No abstract available.
Sokolova MV, Hagen M, Bang H, Schett G, Rech J, Steffen U; RETRO study group. IgA anti-citrullinated protein antibodies are associated with flares during DMARD tapering in rheumatoid arthritis.
Rheumatology (Oxford). 2022 May 5;61(5):2124-2131. doi: 10.1093/rheumatology/keab585.
PMID: 34508547
Simon D, Tascilar K, Schmidt K, Manger B, Weckwerth L, Sokolova M, Bucci L, Fagni F, Manger K, Schuch F, Ronneberger M, Hueber A, Steffen U, Mielenz D, Herrmann M, Harrer T, Kleyer A, Krönke G, Schett G. Humoral and Cellular Immune Responses to SARS-CoV-2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion.
Arthritis Rheumatol. 2022 Jan;74(1):33-37. doi: 10.1002/art.41914. Epub 2021 Nov 23.
PMID: 34196506
Simon D, Tascilar K, Kleyer A, Fagni F, Krönke G, Meder C, Dietrich P, Orlemann T, Kliem T, Mößner J, Liphardt AM, Schönau V, Bohr D, Schuster L, Hartmann F, Leppkes M, Ramming A, Pachowsky M, Schuch F, Ronneberger M, Kleinert S, Hueber AJ, Manger K, Manger B, Atreya R, Berking C, Sticherling M, Neurath MF, Schett G. Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS-CoV-2 in an Unvaccinated Cohort.
Arthritis Rheumatol. 2022 May;74(5):783-790. doi: 10.1002/art.42035. Epub 2022 Mar 23. PMID: 34951137
Simon D, Tascilar K, Fagni F, Kleyer A, Krönke G, Meder C, Dietrich P, Orlemann T, Mößner J, Taubmann J, Mutlu MY, Knitza J, Kemenes S, Liphardt AM, Schönau V, Bohr D, Schuster L, Hartmann F, Minopoulou I, Leppkes M, Ramming A, Pachowsky M, Schuch F, Ronneberger M, Kleinert S, Hueber AJ, Manger K, Manger B, Atreya R, Berking C, Sticherling M, Neurath MF, Schett G. Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study.
Lancet Rheumatol. 2022 Sep;4(9):e614-e625. doi: 10.1016/S2665-9913(22)00191-6. Epub 2022 Aug 9.
PMID: 35966645
Manger B, Manger K. Pseudoacrocyanosis: a case for telemedicine in rheumatology. RMD Open. 2022 Sep;8(2):e002573. doi: 10.1136/rmdopen-2022-002573. PMID: 36096525; PMCID: PMC9472203.2021
Simon D, Tascilar K, Schmidt K, Manger B, Weckwerth L, Sokolova M, Bucci L, Fagni F, Manger K, Schuch F, Ronneberger M, Hueber A, Steffen U, Mielenz D, Herrmann M, Harrer T, Kleyer A, Krönke G, Schett G. Brief Report: Humoral and cellular immune responses to SARS-CoV-2 infection and vaccination in B cell depleted autoimmune patients.
Arthritis Rheumatol. 2021 Jul 1. doi: 10.1002/art.41914. Online ahead of print.
PMID: 34196506.
Simon D, Tascilar K, Fagni F, Krönke G, Kleyer A, Meder C, Atreya R, Leppkes
M, Kremer AE, Ramming A, Pachowsky ML, Schuch F, Ronneberger M, Kleinert S,
Hueber AJ, Manger K, Manger B, Berking C, Sticherling M, Neurath MF, Schett G.
SARS-CoV-2 vaccination responses in untreated, conventionally treated and
anticytokine-treated patients with immune-mediated inflammatory diseases. Ann
Rheum Dis. 2021 May 6:annrheumdis-2021-220461. doi:
10.1136/annrheumdis-2021-220461. Epub ahead of print. PMID: 33958324; PMCID:
PMC8103562.2020
Simon D, Tascilar K, Krönke G, Kleyer A, Zaiss MM, Heppt F, Meder C, Atreya
R, Klenske E, Dietrich P, Abdullah A, Kliem T, Corte G, Morf H, Leppkes M,
Kremer AE, Ramming A, Pachowsky M, Schuch F, Ronneberger M, Kleinert S, Maier C,
Hueber AJ, Manger K, Manger B, Berking C, Tenbusch M, Überla K, Sticherling M,
Neurath MF, Schett G. Patients with immune-mediated inflammatory diseases
receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion.
Nat Commun. 2020 Jul 24;11(1):3774. doi: 10.1038/s41467-020-17703-6. PMID:
32709909; PMCID: PMC7382482.
2019
d'Oliveira I, Döltz S, Manger K, Hueber AJ. Handschmerzen, Muskelschmerzen
und Lippenschwellung [Hand pain, muscle pain and swollen lips]. Z Rheumatol.
2019 Sep;78(7):656-659. German. doi: 10.1007/s00393-019-0679-7. PMID: 31359144.
Ham-Karim HA, Ebili HO, Manger K, Fadhil W, Ahmad NS, Richman SD, Ilyas M.
Targeted Next-Generation Sequencing Validates the Use of Diagnostic Biopsies as
a Suitable Alternative to Resection Material for Mutation Screening in
Colorectal Cancer. Mol Diagn Ther. 2019 Jun;23(3):383-393. doi:
10.1007/s40291-019-00388-z. PMID: 30741375.
Hagen M, Englbrecht M, Haschka J, Reiser M, Kleyer A, Hueber A, Manger B,
Figueiredo C, Cobra JF, Tony HP, Finzel S, Kleinert S, Wendler J, Schuch F,
Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Lorenz HM, Nüsslein
H, Alten R, Henes J, Krüger K, Schett G, Rech J. Cost-effective Tapering
Algorithm in Patients with Rheumatoid Arthritis: Combination of Multibiomarker
Disease Activity Score and Autoantibody Status. J Rheumatol. 2019
May;46(5):460-466. doi: 10.3899/jrheum.180028. Epub 2018 Dec 1. PMID: 30504510.2018
Manger K, von Streitberg U, Seitz G, Kleyer A, Manger B. Hard palate
hyperpigmentation-a rare side effect of antimalarials. Arthritis Rheumatol. 2018
Jan;70(1):152. doi: 10.1002/art.40327. Epub 2017 Nov 28. PMID: 28941224.
2017
Figueiredo CP, Bang H, Cobra JF, Englbrecht M, Hueber AJ, Haschka J, Manger
B, Kleyer A, Reiser M, Finzel S, Tony HP, Kleinert S, Wendler J, Schuch F,
Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M,
Lorenz HM, Nuesslein H, Alten R, Henes J, Krueger K, Rech J, Schett G.
Antimodified protein antibody response pattern influences the risk for disease
relapse in patients with rheumatoid arthritis tapering disease modifying
antirheumatic drugs. Ann Rheum Dis. 2017 Feb;76(2):399-407. doi:
10.1136/annrheumdis-2016-209297. Epub 2016 Jun 20. PMID: 27323772.2016
Rech J, Hueber AJ, Finzel S, Englbrecht M, Haschka J, Manger B, Kleyer A,
Reiser M, Cobra JF, Figueiredo C, Tony HP, Kleinert S, Wendler J, Schuch F,
Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M,
Lorenz HM, Nuesslein H, Alten R, Henes J, Krueger K, Schett G. Prediction of
disease relapses by multibiomarker disease activity and autoantibody status in
patients with rheumatoid arthritis on tapering DMARD treatment. Ann Rheum Dis.
2016 Sep;75(9):1637-44. doi: 10.1136/annrheumdis-2015-207900. Epub 2015 Oct 19.
PMID: 26483255; PMCID: PMC5013080.
Haschka J, Englbrecht M, Hueber AJ, Manger B, Kleyer A, Reiser M, Finzel S,
Tony HP, Kleinert S, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-
Haendle M, Wendler J, Schuch F, Ronneberger M, Lorenz HM, Nuesslein H, Alten R,
Demary W, Henes J, Schett G, Rech J. Relapse rates in patients with rheumatoid
arthritis in stable remission tapering or stopping antirheumatic therapy:
interim results from the prospective randomised controlled RETRO study. Ann
Rheum Dis. 2016 Jan;75(1):45-51. doi: 10.1136/annrheumdis-2014-206439. Epub 2015
Feb 6. PMID: 25660991.
2014
Proft F, Steinbach S, Dechant C, Witt M, Reindl C, Schulz S, Vielhauer V,
Hilge R, Laubender RP, Manger K, Nüsslein H, Wendler J, Schuch F, Schulze-Koops
H, Grunke M. Gustatory and olfactory function in patients with granulomatosis
with polyangiitis (Wegener's). Scand J Rheumatol. 2014;43(6):512-8. doi:
10.3109/03009742.2014.915056. Epub 2014 Sep 10. PMID: 25204208.
Richter JG, Häckel B, Manger K, Riechers E, Schmeding A, Thies W, Schneider
M. Welche Faktoren bestimmen die direkten Krankheits-kosten bei Patienten mit
Systemischem Lupus Erythe-matodes in Deutschland? - Subanalyse der LUCIE-Studie
[What factors determine the direct medical costs of patients with systemic lupus
erythematosus in Germany? Subanalysis of the LUCIE study]. Gesundheitswesen.
2014 Jan;76(1):41-3. German. doi: 10.1055/s-0033-1334935. Epub 2013 Mar 19.
PMID: 23512471.2012
Lang VR, Englbrecht M, Rech J, Nüsslein H, Manger K, Schuch F, Tony HP,
Fleck M, Manger B, Schett G, Zwerina J. Risk of infections in rheumatoid
arthritis patients treated with tocilizumab. Rheumatology (Oxford). 2012
May;51(5):852-7. doi: 10.1093/rheumatology/ker223. Epub 2011 Aug 24. PMID:
21865281.2011
Manger B, Lindner A, Manger K, Wacker J, Schett G. Hypertrophe
Osteoarthropathie. Marie-Bamberger-Syndrom [Hypertrophic osteoarthropathy.
Bamberger-Marie disease]. Z Rheumatol. 2011 Sep;70(7):554-60. German. doi:
10.1007/s00393-011-0813-7. PMID: 21735289.
Lang VR, Englbrecht M, Rech J, Nüsslein H, Manger K, Schuch F, Tony HP,
Fleck M, Manger B, Schett G, Zwerina J. Risk of infections in rheumatoid
arthritis patients treated with tocilizumab. Rheumatology (Oxford). 2012
May;51(5):852-7. doi: 10.1093/rheumatology/ker223. Epub 2011 Aug 24. PMID:
21865281.2010
Rech J, Ronneberger M, Englbrecht M, Finzel S, Katzenbeisser J, Manger K,
Manger B, Schett G. Successful treatment of adult-onset Still's disease
refractory to TNF and IL-1 blockade by IL-6 receptor blockade. Ann Rheum Dis.
2011 Feb;70(2):390-2. doi: 10.1136/ard.2010.129403. Epub 2010 Jul 22. PMID:
20650873.
Fürnrohr BG, Wach S, Kelly JA, Haslbeck M, Weber CK, Stach CM, Hueber AJ,
Graef D, Spriewald BM, Manger K, Herrmann M, Kaufman KM, Frank SG, Goodmon E,
James JA, Schett G, Winkler TH, Harley JB, Voll RE. Polymorphisms in the Hsp70
gene locus are genetically associated with systemic lupus erythematosus. Ann
Rheum Dis. 2010 Nov;69(11):1983-9. doi: 10.1136/ard.2009.122630. Epub 2010 May
24. PMID: 20498198; PMCID: PMC3002760.
Nossent J, Kiss E, Rozman B, Pokorny G, Vlachoyiannopoulos P, Olesinska M,
Marchesoni A, Mosca M, Påi S, Manger K, Schneider M, Nielsen H, van Vollenhoven
R, Swaak T. Disease activity and damage accrual during the early disease course
in a multinational inception cohort of patients with systemic lupus
erythematosus. Lupus. 2010 Jul;19(8):949-56. doi: 10.1177/0961203310366572. Epub
2010 Apr 7. PMID: 20375124.2009
Manger K, Nüsslein H, Schett G, Manger B. Rare monogenetic syndromes in
rheumatology practice. Clin Rheumatol. 2009 Jun;28(6):623-30. doi:
10.1007/s10067-009-1117-z. Epub 2009 Feb 18. PMID: 19224127.2007
Chen JA, Meister S, Urbonaviciute V, Rödel F, Wilhelm S, Kalden JR, Manger
K, Voll RE. Sensitive detection of plasma/serum DNA in patients with systemic
lupus erythematosus. Autoimmunity. 2007 Jun;40(4):307-10. doi:
10.1080/08916930701356317. PMID: 17516216.
Metzler C, Miehle N, Manger K, Iking-Konert C, de Groot K, Hellmich B, Gross
WL, Reinhold-Keller E; German Network of Rheumatic Diseases. Elevated relapse
rate under oral methotrexate versus leflunomide for maintenance of remission in
Wegener's granulomatosis. Rheumatology (Oxford). 2007 Jul;46(7):1087-91. doi:
10.1093/rheumatology/kem029. Epub 2007 May 22. PMID: 17519271.
Ott HW, Mattle V, Hadziomerovic D, Licht P, Döinghaus K, Rubbert A, Manger
K, Manger B, Kalden J, Wildt L. Treatment of hereditary angioneurotic oedema
(HANE) with tibolone. Clin Endocrinol (Oxf). 2007 Feb;66(2):180-4. doi:
10.1111/j.1365-2265.2006.02704.x. PMID: 17223985.
Beier F, Balabanov S, Amberger CC, Hartmann U, Manger K, Dietz K, Kötter I,
Brummendorf TH. Telomere length analysis in monocytes and lymphocytes from
patients with systemic lupus erythematosus using multi-color flow-FISH. Lupus.
2007;16(12):955-62. doi: 10.1177/0961203307084299. PMID: 18042589.
Ringwald J, Buettner S, Zimmermann R, Weisbach V, Strasser E, Eckstein R,
Eckel K, Manger K. Thrombin-activatable fibrinolysis inhibitor and activated
factor XII in patients with systemic lupus erythematosus. Thromb Res.
2007;119(1):129-31. doi: 10.1016/j.thromres.2006.01.002. Epub 2006 Feb 8. PMID:
16466780.2006
Momot T, Ahmadi-Simab K, Gause A, Gross WL, Gromnica-Ihle E, Peter HH,
Manger K, Zeidler H, Schmidt RE, Witte T. Lack of association of mannose binding
lectin variant alleles with systemic lupus erythematosus. Ann Rheum Dis. 2006
Feb;65(2):278-9. doi: 10.1136/ard.2005.042929. PMID: 16410540; PMCID:
PMC1798033.
2005
Manger K, Wildt L, Kalden JR, Manger B. Prevention of gonadal toxicity and
preservation of gonadal function and fertility in young women with systemic
lupus erythematosus treated by cyclophosphamide: the PREGO-Study. Autoimmun Rev.
2006 Apr;5(4):269-72. doi: 10.1016/j.autrev.2005.10.001. Epub 2005 Oct 27. PMID:
16697968.
Unger L, Kayser M, Enderlein M, Manger K, Nüsslein H. Glucocorticoidtherapie
bei Kollagenosen [Glucocorticoid therapy in collagen diseases diseases]. Z
Rheumatol. 2005 Apr;64(3):162-9. German. doi: 10.1007/s00393-005-0721-9. PMID:
15868333.2004
Manger K, Dechant C, Kalden JR, Manger B. Clinical images: Periarticular
inflammation in rapidly developing Jaccoud's arthropathy. Arthritis Rheum. 2004
May;50(5):1700. doi: 10.1002/art.20262. PMID: 15146452.2003
Manger K, Kusus M, Forster C, Ropers D, Daniel WG, Kalden JR, Achenbach S,
Manger B. Factors associated with coronary artery calcification in young female
patients with SLE. Ann Rheum Dis. 2003 Sep;62(9):846-50. doi:
10.1136/ard.62.9.846. PMID: 12922957; PMCID: PMC1754656.
Karassa FB, Bijl M, Davies KA, Kallenberg CG, Khamashta MA, Manger K, Michel
M, Piette JC, Salmon JE, Song YW, Tsuchiya N, Yoo DH, Ioannidis JP. Role of the
Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an
international meta-analysis. Arthritis Rheum. 2003 Jul;48(7):1930-8. doi:
10.1002/art.11059. PMID: 12847687.
Manger K, Manger B. Gibt es eine Indikation für TNF alpha-Antagonisten bei
Kollagenosen? [TNF alpha-antagonists in collagen vascular disease]. Z Rheumatol.
2003 Jun;62(3):240-5. German. doi: 10.1007/s00393-003-0530-y. PMID: 12827400.
Hay FR, Mead A, Manger K, Wilson FJ. One-step analysis of seed storage data
and the longevity of Arabidopsis thaliana seeds. J Exp Bot. 2003
Mar;54(384):993-1011. doi: 10.1093/jxb/erg103. PMID: 12598570.2002
Manger K, Manger B, Repp R, Geisselbrecht M, Geiger A, Pfahlberg A, Harrer
T, Kalden JR. Definition of risk factors for death, end stage renal disease, and
thromboembolic events in a monocentric cohort of 338 patients with systemic
lupus erythematosus. Ann Rheum Dis. 2002 Dec;61(12):1065-70. doi:
10.1136/ard.61.12.1065. PMID: 12429536; PMCID: PMC1753955.
Manger K, Manger B. Konsequenzen der verbesserten Prognose des SLE [Sequelae
of improved prognosis of SLE]. Z Rheumatol. 2002 Oct;61(5):532-3. German. doi:
10.1007/s00393-002-0416-4. PMID: 12399880.
Manger K, Repp R, Jansen M, Geisselbrecht M, Wassmuth R, Westerdaal NA,
Pfahlberg A, Manger B, Kalden JR, van de Winkel JG. Fcgamma receptor IIa, IIIa,
and IIIb polymorphisms in German patients with systemic lupus erythematosus:
association with clinical symptoms. Ann Rheum Dis. 2002 Sep;61(9):786-92. doi:
10.1136/ard.61.9.786. PMID: 12176802; PMCID: PMC1754233.2001
Swaak AJ, van den Brink HG, Smeenk RJ, Manger K, Kalden JR, Tosi S, Domljan
Z, Rozman B, Logar D, Pokorny G, Kovacs L, Kovacs A, Vlachoyiannopoulos PG,
Moutsopoulos HM, Chwalinska-Sadowska H, Kiss E, Cikes N, Anic B, Schneider M,
Fischer R, Bombardieri S, Mosca M, Graninger W, Smolen JS. Systemic lupus
erythematosus. Disease outcome in patients with a disease duration of at least
10 years: second evaluation. Lupus. 2001;10(1):51-8. doi:
10.1191/096120301666282314. PMID: 11243510.
Swaak AJ, van de Brink H, Smeenk RJ, Manger K, Kalden JR, Tosi S, Marchesoni
A, Domljan Z, Rozman B, Logar D, Pokorny G, Kovacs L, Kovacs A,
Vlachoyiannopoulos PG, Moutsopoulos HM, Chwalinska-Sadowska H, Dratwianka B,
Kiss E, Cikes N, Anic B, Schneider M, Fischer R, Bombardieri S, Mosca M,
Graninger W, Smolen JS; Study group on incomplete SLE and SLE with disease
duration longer than 10 years. Incomplete lupus erythematosus: results of a
multicentre study under the supervision of the EULAR Standing Committee on
International Clinical Studies Including Therapeutic Trials (ESCISIT).
Rheumatology (Oxford). 2001 Jan;40(1):89-94. doi: 10.1093/rheumatology/40.1.89.
PMID: 11157147.2000
Hundt M, Manger K, Dörner T, Grimbacher B, Kalden P, Rascu A, Weber D,
Burmester GR, Peter HH, Kalden JR, Schmidt RE. Treatment of acute exacerbation
of systemic lupus erythematosus with high-dose intravenous immunoglobulin.
Rheumatology (Oxford). 2000 Nov;39(11):1301-2. doi:
10.1093/rheumatology/39.11.1301. PMID: 11085821.
1999
Swaak AJ, van den Brink HG, Smeenk RJ, Manger K, Kalden JR, Tosi S,
Marchesoni A, Domljan Z, Rozman B, Logar D, Pokorny G, Kovacs L, Kovacs A,
Vlachoyiannopoulos PG, Moutsopoulos HM, Chwalinska-Sadowska H, Dratwianka B,
Kiss E, Cikes N, Branimir A, Schneider M, Fischer R, Bombardieri S, Mosca M,
Smolen JS, et al. Systemic lupus erythematosus: clinical features in patients
with a disease duration of over 10 years, first evaluation. Rheumatology
(Oxford). 1999 Oct;38(10):953-8. doi: 10.1093/rheumatology/38.10.953. PMID:
10534545.1998
Manger K, Repp R, Spriewald BM, Rascu A, Geiger A, Wassmuth R, Westerdaal
NA, Wentz B, Manger B, Kalden JR, van de Winkel JG. Fcgamma receptor IIa
polymorphism in Caucasian patients with systemic lupus erythematosus:
association with clinical symptoms. Arthritis Rheum. 1998 Jul;41(7):1181-9. doi:
10.1002/1529-0131(199807)41:7<1181::AID-ART6>3.0.CO;2-C. PMID: 9663473.
Schwab J, Schwab M, Manger K, Manger B, Wünsch PH, Gottwik M. Churg-Strauss-
Syndrom mit rechtsventrikulärem Tumor [Churg-Strauss syndrome with right
ventricular tumor]. Dtsch Med Wochenschr. 1998 Apr 17;123(16):487-92. German.
doi: 10.1055/s-2007-1023999. PMID: 9589022.
Manger K, Kalden JR. Gastritis und Thoraxschmerzen. Churg-Strauss
vasculitis] [Gastritis and thoracic pain. Churg-Strauss vasculitis]. Med Klin
(Munich). 1998 Mar 15;93(3):190. German. doi: 10.1007/BF03044838. PMID: 9564168.
1996
Rascu A, Manger K, Kraetsch HG, Kalden JR, Manger B. Osteonecrosis in
systemic lupus erythematosus, steroid-induced or a lupus-dependent
manifestation? Lupus. 1996 Aug;5(4):323-7. doi: 10.1177/096120339600500414.
PMID: 8869906.
Manger K, Kalden JR, Manger B. Cyclosporin A in the treatment of systemic
lupus erythematosus: results of an open clinical study. Br J Rheumatol. 1996
Jul;35(7):669-75. doi: 10.1093/rheumatology/35.7.669. PMID: 8670602.
